Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women.
暂无分享,去创建一个
[1] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[2] S. Leal,et al. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. , 2006, Cancer research.
[3] T. Lehtimäki,et al. A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects , 2005, European Journal of Human Genetics.
[4] John A. Hall,et al. mtDNA mutations increase tumorigenicity in prostate cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] Beth Newman,et al. Comparative analysis of breast cancer risk factors among African-American women and White women. , 2005, American journal of epidemiology.
[6] L. Newman,et al. Breast cancer in African-American women. , 2005, The oncologist.
[7] R. Millikan,et al. Mitochondrial DNA G 10398 A Polymorphism and Invasive Breast Cancer in African-American Women , 2005 .
[8] L. Murri,et al. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? , 2004, Neuroscience Letters.
[9] Z. Djuric,et al. Effects of Low-Fat and/or High Fruit-and-Vegetable Diets on Plasma Levels of 8-Isoprostane-F2α in the Nutrition and Breast Health Study , 2004, Nutrition and cancer.
[10] J. Gilbert,et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk , 2004, Neuroscience Letters.
[11] Douglas Easton,et al. The Genetic Epidemiology of Breast Cancer Genes , 2004, Journal of Mammary Gland Biology and Neoplasia.
[12] H. Soininen,et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia , 2004, Human Genetics.
[13] L. Pianese,et al. Mitochondrial DNA haplogroups influence the Friedreich’s ataxia phenotype , 2004, Journal of Medical Genetics.
[14] N. Roodi,et al. Association of Homozygous Wild-Type Glutathione S-Transferase M1 Genotype with Increased Breast Cancer Risk , 2004, Cancer Research.
[15] J. Haines,et al. Increased Prevalence of the HFE C282Y Hemochromatosis Allele in Women with Breast Cancer , 2004, Cancer Epidemiology Biomarkers & Prevention.
[16] Marty C. Brandon,et al. Effects of Purifying and Adaptive Selection on Regional Variation in Human mtDNA , 2004, Science.
[17] R. Millikan,et al. HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites , 2003, Breast Cancer Research and Treatment.
[18] R. Millikan,et al. Tumor characteristics in African American and white women , 2001, Breast Cancer Research and Treatment.
[19] P. Moorman,et al. Rapid reporting of cancer incidence in a population-based study of breast cancer: one constructive use of a central cancer registry , 1995, Breast Cancer Research and Treatment.
[20] R. Millikan,et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology , 1995, Breast Cancer Research and Treatment.
[21] R. Millikan,et al. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case–control study of African Americans and whites , 2004, Breast Cancer Research.
[22] J. Turrens,et al. Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.
[23] N. Hamasaki,et al. Mitochondrial Oxidative Stress and Mitochondrial DNA , 2003, Clinical chemistry and laboratory medicine.
[24] S. Dimauro,et al. Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.
[25] J. Haines,et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. , 2003, American journal of human genetics.
[26] Thomas A Trikalinos,et al. Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.
[27] Marty C. Brandon,et al. Natural selection shaped regional mtDNA variation in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Schapira,et al. Mitochondrial involvement in Parkinson’s disease , 2002, Neurochemistry International.
[29] K. Majamaa,et al. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population , 2002, Human Genetics.
[30] J. Hopper,et al. Genetic epidemiology of female breast cancer. , 2001, Seminars in cancer biology.
[31] Derek Middleton,et al. Mitochondrial DNA polymorphism: its role in longevity of the Irish population , 2001, Experimental Gerontology.
[32] G. Gururaj,et al. Hunting genes in Parkinson's disease from the roots. , 2001, Medical hypotheses.
[33] J. Liehr,et al. Role of iron in estrogen-induced cancer. , 2001, Current medicinal chemistry.
[34] J. T. Wachsman,et al. Mitochondrial DNA in human malignancy. , 2001, Mutation research.
[35] K. Marder,et al. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease , 2000, Neurology.
[36] D. Wallace,et al. Mitochondrial DNA variation in human evolution and disease. , 1999, Gene.
[37] J. Smeitink,et al. Human mitochondrial complex I in health and disease. , 1999, American journal of human genetics.
[38] D. Wallace. Mitochondrial diseases in man and mouse. , 1999, Science.
[39] N. Vermeulen,et al. Biomarkers of free radical damage applications in experimental animals and in humans. , 1999, Free radical biology & medicine.
[40] N. Roodi,et al. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. , 1998, Cancer research.
[41] D. Charron,et al. Mitochondrial Genotype Associated with French Caucasian Centenarians , 1998, Gerontology.
[42] B. Robinson. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. , 1998, Biochimica et biophysica acta.
[43] R. Millikan,et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[44] L. Cavalli,et al. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? , 1998, Mutation research.
[45] K. Yagi,et al. Mitochondrial genotype associated with longevity , 1998, The Lancet.
[46] H. Ohshima,et al. Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. , 1998, Free radical biology & medicine.
[47] C. Fall,et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.
[48] D. Wallace,et al. Mitochondrial DNA in aging and disease. , 1997, Scientific American.
[49] A. Colell,et al. Direct Effect of Ceramide on the Mitochondrial Electron Transport Chain Leads to Generation of Reactive Oxygen Species , 1997, The Journal of Biological Chemistry.
[50] R. Swerdlow,et al. Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.
[51] S. Papa. Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications. , 1996, Biochimica et biophysica acta.
[52] Yager Jd,et al. Molecular Mechanisms of Estrogen Carcinogenesis , 1996 .
[53] J. Yager,et al. Molecular mechanisms of estrogen carcinogenesis. , 1996, Annual review of pharmacology and toxicology.
[54] L. Excoffier,et al. Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. , 1995, American journal of human genetics.
[55] D. Wallace,et al. Mitochondrial DNA sequence variation in human evolution and disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Torroni,et al. Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance , 1994, Journal of bioenergetics and biomembranes.
[57] L. Loeb,et al. Reactive oxygen species in tumorigenesis. , 1994, Cancer research.
[58] B. Crain,et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.
[59] C R Weinberg,et al. Randomized recruitment in case-control studies. , 1991, American journal of epidemiology.
[60] W. Dupont,et al. Power and sample size calculations. A review and computer program. , 1990, Controlled clinical trials.
[61] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[62] A. H. V. Schapira,et al. MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.
[63] D. Roy,et al. Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. , 1989, Cancer research.
[64] B. Ames,et al. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[65] B. Halliwell,et al. Free radicals in biology and medicine , 1985 .
[66] Rascon. [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.